We are transparent and open about working with commercial organisations, including pharmaceutical companies.
As yet, there is no cure for Huntington’s disease, but every year is a step closer to new drugs and treatments.
Our vision at the Huntington's Disease Association is:
Together, we will build a better life for anyone affected by Huntington’s disease.
We can only do that by working with key stakeholders. The pharmaceutical industry has a crucial role to play in achieving this vision, and collaborating with the industry is something we know our community understands and expects us to do.
We are open and transparent about who we work with in the pharmaceutical industry.
You can read our policy on working with commercial organisations.
Huntington’s Disease Association recognises that collaborating with pharmaceutical companies can provide a platform to share important knowledge and expertise.
We are driven to explore all partnerships that benefit people affected by Huntington’s and do not conflict with the best interests of our beneficiaries. We acknowledge the need to be open and transparent about such partnerships to ensure we maintain our integrity and independence.
